The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

Fri, 20th Mar 2020 15:57

(Alliance News) - The follow is a round-up of share dealings by UK company directors and managers announced on Friday and not separately reported by Alliance News:

----------

Plus500 Ltd - Directors and managers - including Alon Gonen, Gal Haber and Elad Ben Izhak - buy 1.8 million shares at GBP7.66 to GBP8.00, worth about GBP14 million, on Tuesday and Wednesday.

----------

UDG Healthcare PLC - Senior team buy 83,500 shares worth about GBP375,000. Chair Peter Gray buys 20,000 shares at GBP4.50 on Wednesday. CEO Brendan McAtamney buys 25,000 shares at GBP4.54 on Wednesday. General Counsel Damien Moynagh and spouse Anna Moynagh buy 3,000 shares at average GBP4.54 on Wednesday. Non-Executive Director Shane Cooke buys 15,500 shares at GBP4.42 on Wednesday. CFO Nigel Clerkin buys 20,000 shares at GBP5.17 on Thursday.

----------

IWG PLC - CEO Mark Dixon buys 295,800 shares at GBP1.08, worth GBP318,281, on Thursday. Dixon has bought more than 4 million shares this week, spending more than GBP5 million.

----------

Kier Group PLC - Top three buy GBP74,354 in shares. Chair Matthew Lester buys 29,296 shares, Chief Executive Andrew Davies buys 29,294 shares, and CFO Simon Kesterton buys 29,195 shares, all on Thursday at GBP0.847.

----------

Gamesys Group PLC - COO Robeson Reeves buys 35,000 shares at GBP6.53, worth GBP228,550, on Thursday. Now holds 777,400 shares.

----------

Brewin Dolphin Holdings PLC - Robin Beer, managing director of Investment Solutions & Distribution, buys 16,000 shares at 138.4p, worth GBP22,144, on Thursday. Charles Ferry, MD of private clients, buys 15,000 shares at 163.00p, worth GBP24,450, on Friday.

----------

BlackRock Throgmorton Trust PLC - Chair Christopher Samuel buys 25,000 shares at GBP3.35, worth GBP83,750, on Thursday.

----------

LXI REIT PLC - Director Stephen Hubbard buys 36,000 shares at 96.5p, worth GBP34,740, on Friday. He now holds 169,389 shares. Director Colin Smith buys 40,000 shares at 86.5p, worth 34,600, on Thursday. Now holds 222,909 shares.

----------

Greencoat UK Wind PLC - Chair Tim Ingram buys 45,895 shares at 108.40, worth GBP49,750, on Friday. Now holds 485,575 shares.

----------

Henderson Far East Income Ltd - Director John Russell buys 10,000 shares at 244.55p and 244.97p, worth GBP24,476, on Thursday.

----------

QinetiQ Group PLC - CFO David Smith buys 15,705 shares at GBP2.5278, worth GBP39,699, on Thursday.

----------

Oxford BioMedica PLC - Non-Executive Director Martin Diggle, via Vulpes Testudo Fund, buys 7,378 shares at GBP3.83, worth GBP28,251, on Wednesday. Vulpes funds now hold 11.7 million shares, 15% of total.

----------

Jardine Matheson Holdings Ltd - Associate of Director Percy Weatherall sells 2,000 shares at USD49.27, worth USD98,540, in Singapore on Thursday.

----------

XPS Pensions Group PLC - Patrick McCoy, head of Advisory, sells 90,598 shares at GBP1.07, worth GBP96,940, on Friday.

----------

Dalata Hotel Group PLC - Shane Casserly, corporate development director, buys 17,250 shares at EUR1.75, worth EUR30,565, on Thursday. Dermot Crowley, deputy chief executive for Business Development & Finance, buys 10,000 shares at EUR2.00, worth EUR20,000, on Friday.

----------

Alumasc Group PLC - Company corrected that the previously reported purchase of 16,375 shares on Thursday by Luan Leaf, associate of Michael Leaf, divisional managing director of Housebuilding Products Division, was at 67p, rather than 66p.

----------

River & Mercantile Group PLC - CFO Kevin Hayes buys 7,700 shares at 193p, worth GBP14,861, on Tuesday. Now holds 446,405 shares, 0.5% of total.

----------

Ruffer Investment Co Ltd - Non-Executive Director Christopher Russell buys 8,026 preference shares at GBP2.15, worth GBP17,256, on Friday. Now holds 68,026 shares, 0.04% of total.

----------

Syncona Ltd - Non-Executive Director Robert Hutchinson buys 25,480 shares at GBP1.95, worth GBP49,635, on Wednesday.

----------

Gran Tierra Energy Inc - Director Brooke Wade, via Wade Capital Corp, buys 300,000 shares at USD0.20, worth USD60,000, in Toronto on Thursday.

----------

Griffin Mining Ltd - Non-Executive Director Adam Usdan, via Trellus Co LLC, buys 5,000 shares at 32.5p, worth GBP16,250, on Thursday. Now holds 33.3 million shares, 19% of total.

----------

Auto Trader Group PLC - Senior Independent Director David Keens buys 25,000 shares at 361.04p, worth GBP90,250, on Thursday. Now holds 50,000 shares.

----------

AstraZeneca PLC - Non-Executive Director Tony Mok buys 1,000 American Depositary Shares at USD38.32, worth USD38,320, in New York on Wednesday. Each ADS equals two shares.

----------

Kape Technologies PLC - Non-Executive Director David Cotterell buys 52,000 shares at 111p, worth GBP57,720, on Thursday. Now holds 140,544 shares.

----------

Diversified Gas & Oil PLC - Chair David Johnson buys 25,000 shares at 66.2p, worth GBP16,550, on Thursday. Now has interest in 375,000 shares, 0.06%.

----------

Great Portland Estates PLC - Non-Executive Director Richard Mully buys 10,000 shares at 529.64p, worth GBP52,964, on Thursday.

----------

Salt Lake Potash Ltd - Managing Director Tony Swiericzuk buys 363,053 shares at AUD0.354, worth AUD128,733, in a subscription for cash on Tuesday through Thursday. Now holds 3.5 million shares, 1.2% of total.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.